ArticlePloS one2026
Complete genome and functional insights into Microbacterium sp. strain FBCC-B4120, a novel freshwater isolate with diverse biotechnological traits.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The genus Microbacterium encompasses a diverse group of Actinobacteria with broad ecological distribution and functional versatility. Here, we report the complete genome sequence of Microbacterium sp. FBCC-B4120, a novel strain isolated from a freshwater ecosystem in Korea. The genome was assembled into a single circular chromosome of 3.78 Mb with a G + C content of 70.5%, achieving 100% genome completeness. Phylogenomic analysis confirmed that FBCC-B4120 represents a distinct species within the genus, with M. thalassium identified as its closest relative. FBCC-B4120 demonstrated diverse physiological activities such as antimicrobial activity, siderophore production, glycosidase activity, and traits associated with anti-obesity and antiviral effects. Comparative genome analysis revealed a broad repertoire of carbohydrate-active enzymes and a distinct urea utilization cluster, suggesting expanded capacities for carbohydrate metabolism and nitrogen utilization. These findings establish FBCC-B4120 as a novel Microbacterium species with distinctive genomic features and multifunctional traits, highlighting its potential as a valuable resource for future biotechnological applications. However, the functional predictions presented here rely primarily on genomic annotation, and further biochemical validation will be required to confirm these activities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.